message to everyone
Thank you for your continued understanding of iPS cell research. I would like to express my sincere gratitude for the support of many people who have enabled me to continue my iPS cell research. iPS cells are expected to play an important role in realizing regenerative medicine and the development of new drugs. We are currently conducting research with the aim of realizing new treatments using iPS cells for diseases and injuries for which there are no effective treatments. Your support will be used carefully for medical applications and research expenses, for actively recruiting and training excellent researchers who will lead the next generation, and for securing and maintaining intellectual property. We would like to ask for your warm support so that we can deliver medical care using iPS cells to patients and those who support them as soon as possible.
(Jun Takahashi, Director, iPS Cell Research Institute)
from the field of activity
“Cancer Immuno-Regenerative Therapy” Combining iPS Cell Technology and Immunotherapy “Immunotherapy” is a cancer treatment that activates immune cells to attack cancer cells. The Center for iPS Cell Research and Application, Kyoto University is conducting research on "cancer immune regeneration therapy" that combines this immunotherapy and iPS cell technology. Immune cells include T cells and NK cells that attack pathogens and foreign substances such as bacteria and viruses.In this treatment, these immune cells with enhanced ability to target and attack cancer cells are created from iPS cells and administered to patients. From April 2021, in cooperation with the National Cancer Center Hospital East, a clinical trial for ovarian cancer treatment has started. In the future, we aim to apply this technology to the treatment of various cancers and immune disorders, as well as other diseases.
